Download PDF
Semin Respir Crit Care Med 2017; 38(01): 056-065
DOI: 10.1055/s-0036-1597560
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Systemic Thrombolytic Therapy for Acute Pulmonary Embolism: Who Is a Candidate?

Stavros V. Konstantinides
1   Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
2   Department of Cardiology, Democritus University of Thrace, Alexandroupolis, Greece
,
Stefano Barco
1   Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
16 February 2017 (online)

    Permissions and Reprints

Abstract

Pulmonary embolism (PE) is a major cause of both acute and long-term morbidity for a large number of patients worldwide, and massive PE is frequently fatal. Right ventricular (RV) dysfunction is a key determinant of prognosis in the acute phase of PE. Patients with clinically overt RV failure, that is, with cardiogenic shock or persistent hypotension at presentation (acute high-risk PE), are clearly in need of immediate reperfusion treatment with systemic thrombolysis or, alternatively, surgical or catheter-directed techniques. On the other hand, within the large group of patients presenting without hemodynamic instability, the bleeding risk of full-dose intravenous thrombolytic treatment has been shown to outweigh its benefits, even if they present with evidence of both RV dysfunction and myocardial injury. Thus, current guidelines agree in proposing a strategy of effective anticoagulation and “watchful waiting” (with initial hemodynamic monitoring notably over the first 48–72 hours) in intermediate-risk PE, with an indication for rescue thrombolysis if signs of hemodynamic decompensation appear. Recently published trials suggest that catheter-directed, ultrasound-assisted, low-dose local fibrinolysis may provide an effective and particularly safe treatment option for some of these patients. Ongoing or planned studies are expected to resolve the controversy on the efficacy and safety or reduced-dose systemic thrombolysis and to address the possible impact of thrombolytic therapy on long-term outcomes after acute PE.

Keywords

pulmonary embolism - thrombolysis - risk stratification - guidelines - intravenous - catheter-directed - bleeding - chronic thromboembolic pulmonary hypertension
 

  • References

  • 1 Cohen AT, Agnelli G, Anderson FA , et al; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98 (4) 756-764
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Becattini C, Agnelli G, Lankeit M , et al. Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. Eur Respir J 2016;
    PubMedSearch in Google Scholar
  • 3 Klok FA, van der Hulle T, den Exter PL, Lankeit M, Huisman MV, Konstantinides S. The post-PE syndrome: a new concept for chronic complications of pulmonary embolism. Blood Rev 2014; 28 (6) 221-226
    CrossrefPubMedSearch in Google Scholar
  • 4 Lang IM, Pesavento R, Bonderman D, Yuan JX. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J 2013; 41 (2) 462-468
    CrossrefPubMedSearch in Google Scholar
  • 5 Barco S, Woersching AL, Spyropoulos AC, Piovella F, Mahan CE. European Union-28: an annualised cost-of-illness model for venous thromboembolism. Thromb Haemost 2016; 115 (4) 800-808
    Thieme ConnectPubMedSearch in Google Scholar
  • 6 Mahan CE, Borrego ME, Woersching AL , et al. Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Thromb Haemost 2012; 108 (2) 291-302
    Thieme ConnectPubMedSearch in Google Scholar
  • 7 Konstantinides SV, Torbicki A, Agnelli G , et al; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35 (43) 3033-3069 , 3069a–3069k
    CrossrefPubMedSearch in Google Scholar
  • 8 Konstantinides SV. Trends in incidence versus case fatality rates of pulmonary embolism: good news or bad news?. Thromb Haemost 2016; 115 (2) 233-235
    Thieme ConnectPubMedSearch in Google Scholar
  • 9 Laporte S, Mismetti P, Décousus H , et al; RIETE Investigators. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008; 117 (13) 1711-1716
    CrossrefPubMedSearch in Google Scholar
  • 10 Aujesky D, Obrosky DS, Stone RA , et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172 (8) 1041-1046
    CrossrefPubMedSearch in Google Scholar
  • 11 Jiménez D, Aujesky D, Moores L , et al; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010; 170 (15) 1383-1389
    CrossrefPubMedSearch in Google Scholar
  • 12 Righini M, Roy PM, Meyer G, Verschuren F, Aujesky D, Le Gal G. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. J Thromb Haemost 2011; 9 (10) 2115-2117
    CrossrefPubMedSearch in Google Scholar
  • 13 Harjola VP, Mebazaa A, Čelutkienė J , et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail 2016; 18 (3) 226-241
    CrossrefPubMedSearch in Google Scholar
  • 14 Konstantinides S. Clinical practice. Acute pulmonary embolism. N Engl J Med 2008; 359 (26) 2804-2813
    CrossrefPubMedSearch in Google Scholar
  • 15 Marti C, John G, Konstantinides S , et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 2015; 36 (10) 605-614
    CrossrefPubMedSearch in Google Scholar
  • 16 Chatterjee S, Chakraborty A, Weinberg I , et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA 2014; 311 (23) 2414-2421
    CrossrefPubMedSearch in Google Scholar
  • 17 Meyer G, Vicaut E, Danays T , et al; PEITHO Investigators. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 2014; 370 (15) 1402-1411
    CrossrefPubMedSearch in Google Scholar
  • 18 Stein PD, Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med 2012; 125 (5) 465-470
    CrossrefPubMedSearch in Google Scholar
  • 19 Jiménez D, de Miguel-Díez J, Guijarro R , et al; RIETE Investigators. Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE Registry. J Am Coll Cardiol 2016; 67 (2) 162-170
    PubMedSearch in Google Scholar
  • 20 Wang C, Zhai Z, Yang Y , et al; China Venous Thromboembolism (VTE) Study Group. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. Chest 2010; 137 (2) 254-262
    CrossrefPubMedSearch in Google Scholar
  • 21 Torbicki A, Perrier A, Konstantinides S , et al; ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29 (18) 2276-2315
    CrossrefPubMedSearch in Google Scholar
  • 22 Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M ; “MOPETT” Investigators. Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol 2013; 111 (2) 273-277
    CrossrefPubMedSearch in Google Scholar
  • 23 Armstrong PW, Gershlick AH, Goldstein P , et al; STREAM Investigative Team. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2013; 368 (15) 1379-1387
    CrossrefPubMedSearch in Google Scholar
  • 24 Engelberger RP, Kucher N. Ultrasound-assisted thrombolysis for acute pulmonary embolism: a systematic review. Eur Heart J 2014; 35 (12) 758-764
    CrossrefPubMedSearch in Google Scholar
  • 25 Kucher N, Boekstegers P, Müller OJ , et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation 2014; 129 (4) 479-486
    CrossrefPubMedSearch in Google Scholar
  • 26 Piazza G, Hohlfelder B, Jaff MR , et al; SEATTLE II Investigators. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study. JACC Cardiovasc Interv 2015; 8 (10) 1382-1392
    CrossrefPubMedSearch in Google Scholar
  • 27 Kuo WT, Banerjee A, Kim PS , et al. Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT): initial results from a prospective multicenter registry. Chest 2015; 148 (3) 667-673
    CrossrefPubMedSearch in Google Scholar
  • 28 Engelberger RP, Spirk D, Willenberg T , et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Circ Cardiovasc Interv 2015; 8 (1) 8
    PubMedSearch in Google Scholar
  • 29 Stevinson BG, Hernandez-Nino J, Rose G, Kline JA. Echocardiographic and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients. Eur Heart J 2007; 28 (20) 2517-2524
    CrossrefPubMedSearch in Google Scholar
  • 30 Chung T, Emmett L, Mansberg R, Peters M, Kritharides L. Natural history of right ventricular dysfunction after acute pulmonary embolism. J Am Soc Echocardiogr 2007; 20 (7) 885-894
    CrossrefPubMedSearch in Google Scholar
  • 31 Guérin L, Couturaud F, Parent F , et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thromb Haemost 2014; 112 (3) 598-605
    Thieme ConnectPubMedSearch in Google Scholar
  • 32 Kline JA, Nordenholz KE, Courtney DM , et al. Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost 2014; 12 (4) 459-468
    CrossrefPubMedSearch in Google Scholar
  • 33 Coutance G, Cauderlier E, Ehtisham J, Hamon M, Hamon M. The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis. Crit Care 2011; 15 (2) R103
    CrossrefPubMedSearch in Google Scholar
  • 34 Becattini C, Agnelli G, Vedovati MC , et al. Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test. Eur Heart J 2011; 32 (13) 1657-1663
    CrossrefPubMedSearch in Google Scholar
  • 35 Aviram G, Soikher E, Bendet A , et al. Prediction of mortality in pulmonary embolism based on left atrial volume measured on CT pulmonary angiography. Chest 2016; 149 (3) 667-675
    CrossrefPubMedSearch in Google Scholar
  • 36 Klok FA, Mos IC, Huisman MV. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. Am J Respir Crit Care Med 2008; 178 (4) 425-430
    CrossrefPubMedSearch in Google Scholar
  • 37 Lankeit M, Jiménez D, Kostrubiec M , et al. Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism. Eur Respir J 2014; 43 (6) 1669-1677
    CrossrefPubMedSearch in Google Scholar
  • 38 Bajaj A, Rathor P, Sehgal V , et al. Prognostic value of biomarkers in acute non-massive pulmonary embolism: a systematic review and meta-analysis. Lung 2015; 193 (5) 639-651
    CrossrefPubMedSearch in Google Scholar
  • 39 Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116 (4) 427-433
    CrossrefPubMedSearch in Google Scholar
  • 40 Lankeit M, Jiménez D, Kostrubiec M , et al. Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation 2011; 124 (24) 2716-2724
    CrossrefPubMedSearch in Google Scholar
  • 41 Kaeberich A, Seeber V, Jiménez D , et al. Age-adjusted high-sensitivity troponin T cut-off value for risk stratification of pulmonary embolism. Eur Respir J 2015; 45 (5) 1323-1331
    CrossrefPubMedSearch in Google Scholar
  • 42 Dellas C, Puls M, Lankeit M , et al. Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism. J Am Coll Cardiol 2010; 55 (19) 2150-2157
    CrossrefPubMedSearch in Google Scholar
  • 43 Dellas C, Tschepe M, Seeber V , et al. A novel H-FABP assay and a fast prognostic score for risk assessment of normotensive pulmonary embolism. Thromb Haemost 2014; 111 (5) 996-1003
    Thieme ConnectPubMedSearch in Google Scholar
  • 44 Hellenkamp K, Schwung J, Rossmann H , et al. Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin. Eur Respir J 2015; 46 (6) 1701-1710
    CrossrefPubMedSearch in Google Scholar
  • 45 Becattini C, Agnelli G, Salvi A , et al; TIPES Study Group. Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. Thromb Res 2010; 125 (3) e82-e86
    CrossrefPubMedSearch in Google Scholar
  • 46 Kline JA, Steuerwald MT, Marchick MR, Hernandez-Nino J, Rose GA. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. Chest 2009; 136 (5) 1202-1210
    CrossrefPubMedSearch in Google Scholar
  • 47 Kearon C, Akl EA, Ornelas J , et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016; 149 (2) 315-352
    CrossrefPubMedSearch in Google Scholar
  • 48 Jaff MR, McMurtry MS, Archer SL , et al; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123 (16) 1788-1830
    CrossrefPubMedSearch in Google Scholar
  • 49 Agarwal S, Menon V, Jaber WA. Residential zip code influences outcomes following hospitalization for acute pulmonary embolism in the United States. Vasc Med 2015; 20 (5) 439-446
    CrossrefPubMedSearch in Google Scholar
  • 50 Tsai J, Grosse SD, Grant AM, Hooper WC, Atrash HK. Trends in in-hospital deaths among hospitalizations with pulmonary embolism. Arch Intern Med 2012; 172 (12) 960-961
    PubMedSearch in Google Scholar
  • 51 Yang S, Yang Y, Zhai Z , et al. Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. J Thorac Dis 2015; 7 (11) 1927-1938
    PubMedSearch in Google Scholar
  • 52 de Miguel-Díez J, Jiménez-García R, Jiménez D , et al. Trends in hospital admissions for pulmonary embolism in Spain from 2002 to 2011. Eur Respir J 2014; 44 (4) 942-950
    CrossrefPubMedSearch in Google Scholar
  • 53 Dentali F, Ageno W, Pomero F, Fenoglio L, Squizzato A, Bonzini M. Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy. Thromb Haemost 2016; 115 (2) 399-405
    Thieme ConnectPubMedSearch in Google Scholar
  • 54 Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 2011; 171 (9) 831-837
    CrossrefPubMedSearch in Google Scholar
  • 55 Shiraev TP, Omari A, Rushworth RL. Trends in pulmonary embolism morbidity and mortality in Australia. Thromb Res 2013; 132 (1) 19-25
    CrossrefPubMedSearch in Google Scholar
  • 56 Smith SB, Geske JB, Kathuria P , et al. Analysis of national trends in admissions for pulmonary embolism. Chest 2016; 150 (1) 35-45
    CrossrefPubMedSearch in Google Scholar